Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

YERVOY: Melanoma (adjuvant)

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

• Adjuvant treatment of adult patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection, including total lymphadenectomy.

Broader topic: Melanoma

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
adjuvant
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Scoped from the FDA approved indication for YERVOY (product label). Only dimensions stated in that wording are part of this definition.
      source wording
      • Adjuvant treatment of adult patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection, including total lymphadenectomy.

      Study evidence for this setting

      0 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      No linked study matches these filters. This is a source-coverage gap, not evidence that there are no treatment options.

      Source relationships and population-mapping limitations
      bindings
        mappings

          Download this complete draft source relationship record →

          Preserved source evidence · Not medical advice